Pharmacogenomics of Dolutegravir Pharmacokinetics and Pharmacodynamics: A protocol for a Scoping Review

Ronald Kiguba; Mishael Ssesanga; Munir Pirmohamed

doi:10.17605/osf.io/whnju

January 1, 2026Open Access

Pharmacogenomics of Dolutegravir Pharmacokinetics and Pharmacodynamics: A protocol for a Scoping Review

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore how genetic factors influence the effectiveness and distribution of dolutegravir.
Conduct scoping review
Collect data on pharmacogenomic factors
Analyze pharmacokinetics and pharmacodynamics related to dolutegravir
Identify key genetic biomarkers influencing dolutegravir response
Summarize pharmacokinetic variations across different populations
Highlight implications for personalized treatment approaches

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Scoping review assesses pharmacogenomics affecting dolutegravir pharmacokinetics and dynamics, indicating potential personalized treatment strategies.

Abstract

A scoping review

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kiguba et al. (2026) studied this question.

synapsesocial.com/papers/69a91de0d6127c7a504c1286 https://doi.org/10.17605/osf.io/whnju

View Full Paper

Ask AI

Bookmark

Share

Pharmacogenomics of Dolutegravir Pharmacokinetics and Pharmacodynamics: A protocol for a Scoping Review

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Pharmacogenomics of Dolutegravir Pharmacokinetics and Pharmacodynamics: A protocol for a Scoping Review

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading